Battery Ventures Acquires Enzo Biochem for $37 Million, Offering 75% Premium to Shareholders
Enzo Biochem, Inc. has been acquired by Battery Ventures in an all-cash deal valued at approximately $37 million, offering a significant premium to the company’s recent stock performance.
2 minutes to read